AAOI vs CURI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 19, 2026

AAOI

43.4
AI Score
VS
AAOI Wins

CURI

32.6
AI Score

Investment Advisor Scores

AAOI

43score
Recommendation
HOLD

CURI

33score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AAOI CURI Winner
Revenue 343.07M 38.41M AAOI
Net Income -37.06M 7.55M CURI
Net Margin -10.8% 19.7% CURI
Operating Income -37.72M 7.64M CURI
ROE -2.2% 18.2% CURI
ROA -1.6% 11.2% CURI
Total Assets 2.30B 67.47M AAOI
Cash 499.74M 5.38M AAOI
Current Ratio 2.78 0.78 AAOI

Relative Price Performance (Last 90 Days)

AAOI 1M: +7.5% · 3M: -40.7% CURI 1M: +20.9% · 3M: +11.4%

Current Technical Phase

AAOI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.5%), weak momentum, RSI 43

RSI (14): 42.9 · Price: $107.63

CURI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.7 · Price: $2.84

Fundamentals Snapshot

Metric AAOI CURI
Market Cap
Forward P/E 23.4 9.2
Trailing P/E
Revenue (TTM)
Revenue Growth 0.9% 0.2%
Gross Margin 0.3% 0.6%
Operating Margin -0.1% 0.4%
EPS -0.77 -0.01
Dividend Yield 0.11%

Frequently Asked Questions

Based on our detailed analysis, AAOI is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.